Prathyusha Duraibabu

Insider Reports History

Location
Richmond, CA
Signature
/s/ William R. Kolb, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Prathyusha Duraibabu:

Company Role Class Num Shares Value Price $ Report Date Ownership
Organogenesis Holdings Inc. Director Class A Common Stock 247,047 $733,410 $3.70 18 Feb 2026 Direct
SANGAMO THERAPEUTICS, INC PRINCIPAL FINANCIAL OFFICER Common Stock 660,042 $263,026 $0.3985 22 Jan 2026 Direct
SANGAMO THERAPEUTICS, INC PRINCIPAL FINANCIAL OFFICER Stock Option (Right to Buy) 560,000 25 Feb 2025 Direct

Insider Reports Filed by Prathyusha Duraibabu

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORGO Organogenesis Holdings Inc. 18 Feb 2026 1 $0 4 Director 20 Feb 2026, 17:26
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2026 1 -$14,615 4 PRINCIPAL FINANCIAL OFFICER 26 Jan 2026, 16:13
SGMO SANGAMO THERAPEUTICS, INC 24 Nov 2025 1 -$1,060 4 PRINCIPAL FINANCIAL OFFICER 26 Nov 2025, 16:07
SGMO SANGAMO THERAPEUTICS, INC 22 Oct 2025 1 -$29,848 4 PRINCIPAL FINANCIAL OFFICER 24 Oct 2025, 17:00
SGMO SANGAMO THERAPEUTICS, INC 24 Aug 2025 1 -$1,051 4 SVP, CHIEF FINANCIAL OFFICER 26 Aug 2025, 20:00
SGMO SANGAMO THERAPEUTICS, INC 22 Jul 2025 1 -$15,289 4 SVP, CHIEF FINANCIAL OFFICER 24 Jul 2025, 16:59
SGMO SANGAMO THERAPEUTICS, INC 24 May 2025 1 -$848 4 SVP, CHIEF FINANCIAL OFFICER 28 May 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 22 Apr 2025 1 -$24,738 4 SVP, CHIEF FINANCIAL OFFICER 24 Apr 2025, 16:09
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2025 4 -$3,107 4 SVP, CHIEF FINANCIAL OFFICER 26 Feb 2025, 17:31
ORGO Organogenesis Holdings Inc. 19 Feb 2025 1 $0 4 Director 21 Feb 2025, 17:38
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2025 1 -$148,628 4 SVP, CHIEF FINANCIAL OFFICER 24 Jan 2025, 16:05
SGMO SANGAMO THERAPEUTICS, INC 24 Nov 2024 2 -$6,019 4 SVP, CHIEF FINANCIAL OFFICER 26 Nov 2024, 16:08
SGMO SANGAMO THERAPEUTICS, INC 24 Aug 2024 2 -$2,716 4 SVP, CHIEF FINANCIAL OFFICER 27 Aug 2024, 16:37
SGMO SANGAMO THERAPEUTICS, INC 11 Jun 2024 1 -$542 4 SVP, CHIEF FINANCIAL OFFICER 13 Jun 2024, 16:42
SGMO SANGAMO THERAPEUTICS, INC 24 May 2024 2 -$1,895 4 SVP, CHIEF FINANCIAL OFFICER 29 May 2024, 16:57
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2024 2 -$10,088 4 SVP, CHIEF FINANCIAL OFFICER 27 Feb 2024, 17:12
ORGO Organogenesis Holdings Inc. 21 Feb 2024 1 $0 4 Director 23 Feb 2024, 17:20
SGMO SANGAMO THERAPEUTICS, INC 22 Jan 2024 1 $0 4 SVP, CHIEF FINANCIAL OFFICER 24 Jan 2024, 16:41
SGMO SANGAMO THERAPEUTICS, INC 25 Nov 2023 1 -$508 4 SVP, Chief Financial Officer 28 Nov 2023, 16:17
SGMO SANGAMO THERAPEUTICS, INC 25 Aug 2023 1 -$1,023 4 SVP, Chief Financial Officer 29 Aug 2023, 16:14
SGMO SANGAMO THERAPEUTICS, INC 11 Jun 2023 1 -$1,028 4 SVP, Chief Financial Officer 13 Jun 2023, 16:55
SGMO SANGAMO THERAPEUTICS, INC 25 May 2023 1 -$1,766 4 SVP, Chief Financial Officer 30 May 2023, 16:41
SGMO SANGAMO THERAPEUTICS, INC 25 Mar 2023 1 -$573 4 SVP, Chief Financial Officer 28 Mar 2023, 17:04
SGMO SANGAMO THERAPEUTICS, INC 24 Feb 2023 3 -$18,700 4 SVP, Chief Financial Officer 06 Mar 2023, 16:07
ORGO Organogenesis Holdings Inc. 22 Feb 2023 1 $0 4 Director 24 Feb 2023, 16:47
SGMO SANGAMO THERAPEUTICS, INC 11 Jun 2022 1 -$3,249 4/A SVP, Chief Financial Officer 06 Feb 2023, 17:28
SGMO SANGAMO THERAPEUTICS, INC 25 Apr 2022 1 -$3,197 4 Vice President, Finance 27 Apr 2022, 17:08
SGMO SANGAMO THERAPEUTICS, INC 25 Mar 2022 1 -$1,984 4 Vice President, Finance 29 Mar 2022, 16:41
SGMO SANGAMO THERAPEUTICS, INC 25 Feb 2022 3 -$20,497 4 Vice President, Finance 01 Mar 2022, 16:18
ORGO Organogenesis Holdings Inc. 15 Feb 2022 1 $0 4 Director 17 Feb 2022, 18:03
ORGO Organogenesis Holdings Inc. 19 Nov 2021 1 $0 4 Director 23 Nov 2021, 18:15
ORGO Organogenesis Holdings Inc. 19 Nov 2021 0 $0 3 Director 23 Nov 2021, 18:10
SGMO SANGAMO THERAPEUTICS, INC 11 Jun 2021 2 $0 4 SVP, CFO, PFO and PAO 14 Jun 2021, 19:17